359 related articles for article (PubMed ID: 22000355)
21. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
22. Concurrent pulmonary Aspergillus and non-Aspergillus mold infections in allogeneic hematopoetic cell transplant recipients.
Gali V; Kaltsas A; Cintrón M; Papanicolaou GA; Lee YJ
Transpl Immunol; 2023 Feb; 76():101745. PubMed ID: 36379375
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients.
Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Solé J; Gavaldá J; Roman A
Transpl Infect Dis; 2016 Feb; 18(1):70-8. PubMed ID: 26678668
[TBL] [Abstract][Full Text] [Related]
24. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
[TBL] [Abstract][Full Text] [Related]
25. IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
Wójtowicz A; Gresnigt MS; Lecompte T; Bibert S; Manuel O; Joosten LA; Rüeger S; Berger C; Boggian K; Cusini A; Garzoni C; Hirsch HH; Weisser M; Mueller NJ; Meylan PR; Steiger J; Kutalik Z; Pascual M; van Delden C; van de Veerdonk FL; Bochud PY; ;
J Infect Dis; 2015 May; 211(10):1646-57. PubMed ID: 25398456
[TBL] [Abstract][Full Text] [Related]
26. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
Silveira FP; Kwak EJ; Paterson DL; Pilewski JM; McCurry KR; Husain S
J Heart Lung Transplant; 2008 Aug; 27(8):850-5. PubMed ID: 18656797
[TBL] [Abstract][Full Text] [Related]
27. Overview of systemic fungal infections.
Rolston K
Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):11-4. PubMed ID: 11757845
[TBL] [Abstract][Full Text] [Related]
28. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
Fukuda T; Boeckh M; Carter RA; Sandmaier BM; Maris MB; Maloney DG; Martin PJ; Storb RF; Marr KA
Blood; 2003 Aug; 102(3):827-33. PubMed ID: 12689933
[TBL] [Abstract][Full Text] [Related]
29. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
Singh N
Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
[TBL] [Abstract][Full Text] [Related]
30. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?
Muñoz P; Singh N; Bouza E
Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385
[TBL] [Abstract][Full Text] [Related]
31. Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
Shoham S; Ostrander D; Marr K
Transpl Infect Dis; 2015 Jun; 17(3):493-6. PubMed ID: 25846433
[TBL] [Abstract][Full Text] [Related]
32. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
33. [Current indications for voriconazole in onco-hematological patients].
Jarque I; Sanz MA
Rev Iberoam Micol; 2007 Sep; 24(3):213-6. PubMed ID: 17874858
[TBL] [Abstract][Full Text] [Related]
34. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.
Anesi JA; Baddley JW
Infect Dis Clin North Am; 2016 Mar; 30(1):277-96. PubMed ID: 26739603
[TBL] [Abstract][Full Text] [Related]
35. [Prophylaxis against fungal infections in solid organ and hematopoietic stem cells transplantation].
Rabagliati R; Santolaya ME
Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S11-8. PubMed ID: 23282550
[TBL] [Abstract][Full Text] [Related]
36. Invasive mold infections in allogeneic bone marrow transplant recipients.
Baddley JW; Stroud TP; Salzman D; Pappas PG
Clin Infect Dis; 2001 May; 32(9):1319-24. PubMed ID: 11303267
[TBL] [Abstract][Full Text] [Related]
37. How We Approach Combination Antifungal Therapy for Invasive Aspergillosis and Mucormycosis in Transplant Recipients.
Haidar G; Singh N
Transplantation; 2018 Nov; 102(11):1815-1823. PubMed ID: 29975240
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
Klingspor L; Saaedi B; Ljungman P; Szakos A
Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
[TBL] [Abstract][Full Text] [Related]
39. Fungal infections in immunocompromised patients.
Sganga G
Mycoses; 2011 Dec; 54 Suppl 4():1-3. PubMed ID: 22126521
[No Abstract] [Full Text] [Related]
40. [Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].
Quindós G
Rev Iberoam Micol; 2011; 28(3):110-9. PubMed ID: 21700230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
